L van Alphen

2.7k total citations
65 papers, 1.9k citations indexed

About

L van Alphen is a scholar working on Microbiology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, L van Alphen has authored 65 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Microbiology, 43 papers in Epidemiology and 16 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in L van Alphen's work include Bacterial Infections and Vaccines (50 papers), Pneumonia and Respiratory Infections (38 papers) and Monoclonal and Polyclonal Antibodies Research (15 papers). L van Alphen is often cited by papers focused on Bacterial Infections and Vaccines (50 papers), Pneumonia and Respiratory Infections (38 papers) and Monoclonal and Polyclonal Antibodies Research (15 papers). L van Alphen collaborates with scholars based in Netherlands, United Kingdom and Finland. L van Alphen's co-authors include J. Dankert, H M Jansen, Paul P. Eijk, H. C. Zanen, K Groeneveld, R J van Ketel, Bob de Wever, S. Marieke van Ham, Alex van Belkum and Henri A. Verbrugh and has published in prestigious journals such as The Lancet, The EMBO Journal and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

L van Alphen

64 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L van Alphen Netherlands 28 1.1k 934 410 348 218 65 1.9k
Porter Anderson United States 29 1.7k 1.6× 2.4k 2.6× 480 1.2× 186 0.5× 377 1.7× 48 3.4k
James C. Parke United States 18 1.1k 1.0× 1.3k 1.4× 237 0.6× 82 0.2× 260 1.2× 30 1.8k
L O Frøholm Norway 25 2.7k 2.5× 2.4k 2.6× 505 1.2× 109 0.3× 165 0.8× 81 3.3k
Hiroshi Watanabe Japan 23 329 0.3× 668 0.7× 417 1.0× 149 0.4× 128 0.6× 131 1.8k
Margaret Dunkley Australia 24 286 0.3× 409 0.4× 297 0.7× 376 1.1× 128 0.6× 54 1.7k
Andrew Gorringe United Kingdom 32 1.8k 1.6× 1.4k 1.5× 703 1.7× 95 0.3× 91 0.4× 109 2.8k
L Nencioni Italy 25 730 0.7× 576 0.6× 366 0.9× 53 0.2× 272 1.2× 52 1.8k
J B Robbins United States 20 673 0.6× 752 0.8× 447 1.1× 65 0.2× 218 1.0× 31 2.0k
G Bjune Norway 19 1.6k 1.4× 1.5k 1.6× 136 0.3× 70 0.2× 98 0.4× 29 1.9k
Lisa A. Lewis United States 29 1.8k 1.6× 1.1k 1.1× 606 1.5× 74 0.2× 87 0.4× 62 2.7k

Countries citing papers authored by L van Alphen

Since Specialization
Citations

This map shows the geographic impact of L van Alphen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L van Alphen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L van Alphen more than expected).

Fields of papers citing papers by L van Alphen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L van Alphen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L van Alphen. The network helps show where L van Alphen may publish in the future.

Co-authorship network of co-authors of L van Alphen

This figure shows the co-authorship network connecting the top 25 collaborators of L van Alphen. A scholar is included among the top collaborators of L van Alphen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L van Alphen. L van Alphen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vries, Jutte J.C. de, Laura Bungener, Wouter ter Veer, et al.. (2008). Incorporation of LpxL1, a detoxified lipopolysaccharide adjuvant, in influenza H5N1 virosomes increases vaccine immunogenicity. Vaccine. 27(6). 947–955. 24 indexed citations
2.
3.
Postma, Maarten J., et al.. (2006). Cost-effectiveness of nation-wide infant vaccination with the 7-valent pneumococcal conjugate vaccine in The Netherlands. European Journal of Public Health. 16. 52–52. 2 indexed citations
4.
5.
Welte, R, J.D. Bos, L van Alphen, et al.. (2004). Economic evaluation of meningococcal serogroup C conjugate vaccination programmes in The Netherlands and its impact on decision-making. Vaccine. 23(4). 470–479. 36 indexed citations
6.
Vermont, Clementien L., Anneke Kuipers, Arie van der Ende, et al.. (2003). Cross-Reactivity of Antibodies against PorA after Vaccination with a Meningococcal B Outer Membrane Vesicle Vaccine. Infection and Immunity. 71(4). 1650–1655. 39 indexed citations
7.
Vogel, L, Frans J. Hoek, T.A. Out, et al.. (1997). Iron-binding proteins in sputum of chronic bronchitis patients with Haemophilus influenzae infections. European Respiratory Journal. 10(10). 2327–2333. 9 indexed citations
8.
Meulen, Freerk W. van der, et al.. (1997). Photodynamic destruction of Haemophilus parainfluenzae by endogenously produced porphyrins. Journal of Photochemistry and Photobiology B Biology. 40(3). 204–208. 43 indexed citations
9.
Alphen, L van, et al.. (1996). Mechanism of Antibody-Mediated Reduction of Nasopharyngeal Colonization by Haemophilus influenzae Type b Studied in an Infant Rat Model. The Journal of Infectious Diseases. 174(6). 1337–1340. 25 indexed citations
10.
Jansen, H M, A. P. E. Sachs, & L van Alphen. (1995). Predisposing Conditions to Bacterial Infections in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 151(6). 2073–2080. 33 indexed citations
11.
Alphen, L van, H M Jansen, & J. Dankert. (1995). Virulence Factors in the Colonization and Persistence of Bacteria in the Airways. American Journal of Respiratory and Critical Care Medicine. 151(6). 2094–2099. 46 indexed citations
12.
Möller, L V, et al.. (1995). Multiple Haemophilus influenzae Strains and Strain Variants Coexist in the Respiratory Tract of Patients with Cystic Fibrosis. The Journal of Infectious Diseases. 172(5). 1388–1392. 50 indexed citations
13.
Alphen, L van. (1992). Epidemiology and Prevention of Respiratory Tract Infections Due to Nonencapsulated Haemophllus influenzae. The Journal of Infectious Diseases. 165(Supplement 1). S177–S180. 18 indexed citations
14.
Ham, S. Marieke van, L van Alphen, & Frits R. Mooi. (1992). Fimbria-Mediated Adherence and Hemagglutination of Haemophilus influenzae. The Journal of Infectious Diseases. 165(Supplement 1). S97–S99. 7 indexed citations
15.
Sterk, L.M.Th., et al.. (1991). Differential binding of Haemophilus influenzae to human tissues by fimbriae. Journal of Medical Microbiology. 35(3). 129–138. 17 indexed citations
16.
Poole, Joyce, et al.. (1991). A family showing inheritance of the Anton blood group antigen An Wj and independence of An Wj from Lutheran. Transfusion Medicine. 1(4). 245–251. 14 indexed citations
17.
Sturm, A. W., et al.. (1990). Outbreak of multiresistant non-encapsulated Haemophilus influenzae infections in a pulmonary rehabilitation centre. The Lancet. 335(8683). 214–216. 26 indexed citations
18.
Ketel, R J van, Bob de Wever, & L van Alphen. (1990). Detection of Haemophilus influenzae in cerebrospinal fluids by polymerase chain reaction DNA amplification. Journal of Medical Microbiology. 33(4). 271–276. 97 indexed citations
19.
Groeneveld, K, L van Alphen, Paul P. Eijk, H M Jansen, & H. C. Zanen. (1988). Changes in Outer Membrane Proteins of Nontypable Haemophilus influenzae in Patients with Chronic Obstructive Pulmonary Disease. The Journal of Infectious Diseases. 158(2). 360–365. 64 indexed citations
20.
Alphen, L van, et al.. (1988). Interaction of Haemophilus influenzae with human erythrocytes and oropharyngeal epithelial cells is mediated by a common fimbrial epitope. Infection and Immunity. 56(7). 1800–1806. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Porter Anderson Breakdown of academic impact, for papers by James C. Parke Breakdown of academic impact, for papers by L O Frøholm Breakdown of academic impact, for papers by Hiroshi Watanabe Breakdown of academic impact, for papers by Margaret Dunkley Breakdown of academic impact, for papers by Andrew Gorringe Breakdown of academic impact, for papers by L Nencioni Breakdown of academic impact, for papers by J B Robbins Breakdown of academic impact, for papers by G Bjune Breakdown of academic impact, for papers by Lisa A. Lewis
Rankless by CCL
2026